## **Core Concept**
Proton pump inhibitors (PPIs) are a class of medications used to reduce gastric acid secretion. They work by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells. Some PPIs are available in intravenous (IV) formulations for use in critical care or perioperative settings.

## **Why the Correct Answer is Right**
The correct answer, **Pantoprazole**, is a proton pump inhibitor that is available in an intravenous formulation. Pantoprazole IV is used in the management of conditions like gastroesophageal reflux disease (GERD) with erosive esophagitis, Zollinger-Ellison syndrome, and in critical care settings where oral administration is not feasible. It effectively reduces gastric acid production.

## **Why Each Wrong Option is Incorrect**
- **Option A: Omeprazole** - While omeprazole is a commonly used PPI, it is not typically available in an IV formulation for clinical use. It is primarily administered orally.
- **Option B: Lansoprazole** - Lansoprazole is another PPI that is mainly administered orally. There is no common IV formulation for lansoprazole.
- **Option D: Rabeprazole** - Rabeprazole is also primarily given orally and does not have a widely used or available IV formulation.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that when IV administration of a PPI is required, such as in critical care settings or when patients are unable to take medications orally, **pantoprazole** and **esomeprazole** are the PPIs that are commonly available in IV formulations. This makes **pantoprazole** a valuable option in these scenarios.

## **Correct Answer:** . Pantoprazole